» Articles » PMID: 16453013

Mechanisms of Progression and Regression of Renal Lesions of Chronic Nephropathies and Diabetes

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2006 Feb 3
PMID 16453013
Citations 207
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of chronic kidney diseases is increasing worldwide, and these conditions are emerging as a major public health problem. While genetic factors contribute to susceptibility and progression of renal disease, proteinuria has been claimed as an independent predictor of outcome. Reduction of urinary protein levels by various medications and a low-protein diet limits renal function decline in individuals with nondiabetic and diabetic nephropathies to the point that remission of the disease and regression of renal lesions have been observed in experimental animals and even in humans. In animal models, regression of glomerular structural changes is associated with remodeling of the glomerular architecture. Instrumental to this discovery were 3D reconstruction studies of the glomerular capillary tuft, which allowed the quantification of sclerosis volume reduction and capillary regeneration upon treatment. Regeneration of capillary segments might result from the contribution of resident cells, but progenitor cells of renal or extrarenal origin may also have a role. This review describes recent advances in our understanding of the mechanisms and mediators underlying renal tissue repair ultimately responsible for regression of renal injury.

Citing Articles

Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications.

Leon-Jimenez D, Sridhar V, Lopez-Mendoza M, Scholtes R, Schmieder R, Cherney D Clin Kidney J. 2025; 18(1):sfae370.

PMID: 40008354 PMC: 11852268. DOI: 10.1093/ckj/sfae370.


Chronic Complications of Diabetes: Prevalence, Prevention, and Management.

Migdalis I J Clin Med. 2024; 13(23).

PMID: 39685460 PMC: 11642689. DOI: 10.3390/jcm13237001.


Untangling the Uncertain Role of Overactivation of the Renin-Angiotensin-Aldosterone System with the Aging Process Based on Sodium Wasting Human Models.

Thimm C, Adjaye J Int J Mol Sci. 2024; 25(17).

PMID: 39273282 PMC: 11394713. DOI: 10.3390/ijms25179332.


Therapeutic potential of vitamin D3 in mitigating high glucose‑induced renal damage: Mechanistic insights into oxidative stress inhibition and TXNIP/NLRP3 signaling pathway blockade.

Li G, He S, Liu T, Zheng N Exp Ther Med. 2024; 28(1):277.

PMID: 38800040 PMC: 11117114. DOI: 10.3892/etm.2024.12565.


Fractional Excretion of Urate is Positively Associated with Type 2 Diabetes in HUA Patients: A Cross-Sectional Study.

Huang B, Li X, Zhang X, Li S, Liu Y, Zhang M Diabetes Metab Syndr Obes. 2024; 17:1701-1713.

PMID: 38633278 PMC: 11022882. DOI: 10.2147/DMSO.S454711.


References
1.
Barnett A, Bain S, Bouter P, Karlberg B, Madsbad S, Jervell J . Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med. 2004; 351(19):1952-61. DOI: 10.1056/NEJMoa042274. View

2.
Habib R, Kleinknecht C, Gubler M, Levy M . Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases. Clin Nephrol. 1973; 1(4):194-214. View

3.
Fioretto P, Steffes M, Sutherland D, Goetz F, Mauer M . Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998; 339(2):69-75. DOI: 10.1056/NEJM199807093390202. View

4.
Remuzzi G, Schieppati A, Ruggenenti P . Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med. 2002; 346(15):1145-51. DOI: 10.1056/NEJMcp011773. View

5.
Shankland S, Eitner F, Hudkins K, Goodpaster T, DAgati V, Alpers C . Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int. 2000; 58(2):674-83. DOI: 10.1046/j.1523-1755.2000.00213.x. View